摘要
目的:观察灯盏细辛注射液治疗血瘀型急性脑梗死的临床疗效。方法:将60例患者随机分为2组各30例。2组均给予相同的基础治疗,治疗组同时给予灯盏细辛注射液静脉滴注,对照组同时给予低分子肝素(速避凝)皮下注射。观察治疗前后血瘀证积分和神经功能缺损积分变化情况。结果:总有效率治疗组为86.67%,对照组为63.33%,2组比较,差异有显著性意义(P<0.05)。2组治疗后血瘀证积分、神经功能缺损积分均有显著降低,治疗前后比较,差异均有非常显著性意义(P<0.01);但治疗组降低更为明显,2组治疗后比较,差异有显著性意义(P<0.05),治疗组疗效优于对照组。结论:灯盏细辛注射液治疗血瘀型脑梗死安全有效,疗效优于速避凝。
Objective:To observe the therapeutic effect of Dengzhan Xixin Injection(DXI) for the treatment of acute cerebral infarction(ACI) with blood stasis.Methods:Sixty patients were equally randomized into 2 groups.The two groups received the same routine western treatment,and additionally the treatment group received intravenous injection of DXI and the control group received subcutaneous injection of low molecular weight heparin.The score of blood-stasia syndrome and neurological deficit was observed before and after treatment.Results:The total effective rate was 86.67%in the treatment group and 63.33%in the control group,the difference being significant between the two groups(P<0.05).The scores of blood-stasis syndrome and neurological deficit were decreased in the two groups after treatment(P<0.01 compared with that before treatment), and the decrease was obvious in the treatment group(P<0.05).Conclusion:DXI is effective and safe for the treatment of acute cerebral infarction(ACI) with blood stasis,and its effect is better than low molecular weight heparin.
出处
《新中医》
CAS
北大核心
2009年第6期19-20,共2页
New Chinese Medicine
基金
2008年度广东省中医药局建设中医药强省科研课题(编号:2008256)
